Industry news

Latest News

Straumann launches new CADCAM dental restoration system

Neuronetics selected by World Economic Forum as 2011 Technology Pioneer

Quidel Announces FDA Clearance of Its RapidVue(R) hCG Pregnancy Lateral Flow Diagnostic Test

Allergan, Inc. Receives FDA Approval for LUMIGAN(R) 0.01% as First-Line Therapy Indicated for the Reduction of Elevated Intraocular Pressure in Glaucoma Patients

GSK and Valeant Announce New U.S. FDA PDUFA Goal Date for Ezogabine

EISAI ANNOUNCES EXTENSION OF FDA REVIEW OF DRUG APPLICATION FOR INVESTIGATIONAL AGENT ERIBULIN MESYLATE

Roche provides update on FDA application for T-DM1

Novartis receives FDA approval of Tekamlo(TM), a single-pill combination of aliskiren and amlodipine to treat high blood pressure

King Pharmaceuticals Launches CYANOKIT

Genentech Provides Update on FDA Application for T-DM1

More news... | RSS Feed...

Most Viewed

Depomed Reaches SPA Agreement With FDA for Phase 3 Hot Flash Trial

FDA: Aseptic Meningitis Risk with Use of Seizure Drug Lamictal

MESOBLAST ON TRACK FOR PHASE 3 BONE MARROW TRANSPLANT TRIAL FOLLOWING POSITIVE MEETING WITH FDA

PSI-7977 Receives Fast Track Designation from the FDA for the Treatment of Chronic Hepatitis C Infection

Ezogabine receives positive vote from FDA advisory committee

FDA Grants Urigen's URG101 Meeting

Watson Plans Q4 2010 ella(R) (ulipristal acetate) Emergency Contraceptive Launch

Advanced Life Sciences Announces Deadline to Exercise Unit Warrants Sold in July 2010 Offering

Pharming Plans Submission Rhucin BLA To Us FDA End 2010

Advanced Life Sciences Achieves Special Protocol Assessment Agreement With FDA for Restanza in Pneumonia

Therapeutic Target

Cardiovascular

Dermatology

Endocrine and Metabolic

Gastroenterology

Genitourinary

Hematology

Immunology and Allergy

Infection

Musculoskeletal

Neurology

Obstetrics and Gynecology

Oncology

Ophthalmology

Psychiatry

Pulmonary

Categories

Deals and Alliances

Development

Financial Results

Financings

Intellectual Property

Regulatory

Press releases

Deals review

Headlines

PR Newswire